Aydan ÇELEBİLER, Hüseyin ŞEKER, Bora YÜKSEL, Ahmet ORUN

Discovery of the connection among age-related macular degeneration, MTHFR C677T and PAI 1 4G/5G gene polymorphisms, and body mass index by means of Bayesian inference methods

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly. The aim of this study was therefore to explore the relationship between the presence of multiple gene polymorphisms and 2 distinct advanced `dry and wet' AMD phenotypes, and to assess gene interactions with the influence of personal factors in a Turkish population as a pilot study. For the analysis, the data were collected from 73 unrelated participants, grouped as 29 wet and 26 dry AMD patients, and 18 healthy controls. They were all genotyped for the multiple gene polymorphisms in 12 different genes. The data set collected was then analyzed using the Bayesian inference methods and visualized by means of the Bayesian networks. The results suggest that: 1) the PAI-1 4G/5G and FV G1691A genes have joint roles in the separation of the 3 groups; 2) both wet and dry AMD can be separated from the control group using the genes PAI-1 4G/5G, FV G1691A, FXII V34L, and PT G20210A; 3) although the wet AMD and control groups can be separated by the combination of the ACE I/D and B-fibrinogen-455 G-A gene polymorphisms, there seems to be no significant effect of the genes on the separation between the dry AMD and control groups; 4) the wet AMD and control groups can be distinguished by the combination of body mass index and the MTHFR-C677T and PAI-1 genes; and 5) there is a correlation between wet AMD and a high body mass index (>30 kg/m2). It was also found that the impact of body mass index on the disease development seems only in question with the connective availability of the genes MTHFR C677T and PAI-1. It can be concluded that the combination of the MTHFR C677T and PAI-1 4G/5G gene polymorphisms in the presence of obesity may increase the risk of wet AMD. In addition, the results further support a complex interplay among genetic and environmental factors in the development of different phenotypes.

Anahtar Kelimeler:

Age-related macular degeneration, body mass index, MTHFR C677T, PAI-1 4G/5G, gene--gene interaction, Bayesian network

Discovery of the connection among age-related macular degeneration, MTHFR C677T and PAI 1 4G/5G gene polymorphisms, and body mass index by means of Bayesian inference methods

Keywords:

Age-related macular degeneration, body mass index, MTHFR C677T, PAI-1 4G/5G, gene--gene interaction, Bayesian network,

PDF

___

D.S. Friedman, B.J. O’Colmain, B. Munoz, S.C. Tomany, C. McCarty, P.T. de Jong, B. Nemesure, P. Mitchell, J. Kempen, “Prevalence of age-related macular degeneration in the United States”, Archives of Ophthalmology, Vol. 122, pp. 564–572, 2004.
A.G. Caswell, D. Kohen, A.C. Bird, “Retinal pigment epithelial detachments in the elderly: classification and outcome”, British Journal of Ophthalmology, Vol. 69, pp. 397–403, 1985.
G.S. Hageman, P.J. Luthert, N.H. Victor Chong, L.V. Johnson, D.H. Anderson, R.F. Mullins, “An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration”, Progress in Retinal and Eye Research, Vol. 20, pp. 705– 732, 2001.
M.A. Zarbin, “Current concepts in the pathogenesis of age-related macular degeneration”, Archives of Ophthalmology, Vol. 122, pp. 598–614, 2004.
F.G. Holz, D. Pauleikhoff, R. Klein, A.C. Bird, “Pathogenesis of lesions in late age-related macular disease”, American Journal of Ophthalmology, Vol. 137, pp. 504–510, 2004.
M.L. Klein, F.L. Ferris 3rd, J. Armstrong, T.S. Hwang, E.Y. Chew, S.B. Bressler, S.R. Chandra, “Retinal precursors and the development of geographic atrophy in age-related macular degeneration”, Ophthalmology, Vol. 115, pp. 1026–1031, 2008.
R.H. Guymer, E. Heon, A.J. Lotery, F.L. Munier, D.F. Schorderet, P.N. Baird, R.J. McNeil, H. Haines, V.C. Sheffield, E.M. Stone, “Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration”, Archives of Ophthalmology, Vol. 119, pp. 745–751, 2001.
D.J. Cameron, Z. Yang, D. Gibbs, H. Chen, Y. Kaminoh, A. Jorgensen, J. Zeng, L. Luo, G. Brinton, J.M. Brand, P.S. Bernstein, N.A. Zabriskie, S. Tang, R. Constantine, Z. Tong, K. Zhang, “HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration”, Cell Cycle, Vol. 6, pp. 1122–1125, 2007. T. Sepp, J.C. Khan, D.A. Thurlby, H. Shahid, D.G. Clayton, A.T. Moore, A.C. Bird, J.R. Yates, “Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and non-smokers”, Investigative Ophthalmology & Visual Science, Vol. 47, pp. 536–540, 2006.
P. Mitchell, J.J. Wang, S. Foran, W. Smith, “Five-year incidence of age-related maculopathy lesions: The Blue Mountains eye study”, Ophthalmology, Vol. 109, pp. 1092–1097, 2002.
R. Klein, B.E. Klein, S.C. Tomany, S.M. Meuer, G.H. Huang, “Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study”, Ophthalmology, Vol. 109, pp. 1767–1779, 2002.
A.C. Bird, N.M. Bressler, S.B. Bressler, I.H. Chisholm, G. Coscas, M.D. Davis, P.T.V.M. de Jong, C.C.W. Klaver, B.E.K. Klein, R. Klein, P. Mitchell, J.P. Sarks, S.H. Sarks, G. Soubrane, H.R. Taylor, J.R. Vingerling, The International ARM Epidemiological Study Group, “An international classification and grading system for agerelated maculopathy and age-related macular degeneration”, Survey of Ophthalmology, Vol. 39, pp. 367–374, 1995. D.R. Guyer, L.A. Yannuzzi, J.S. Slakter, J.A. Sorenson, P. Hanutsaha, R.F. Spaide, S.G. Schwartz, J.M. Hirschfeld, D.A. Orlock, “Classification of choroidal neovascularization by digital indocyanine green videoangiography”, Ophthalmology, Vol. 103, pp. 2054–2060, 1996.
J. Cheng, R. Greiner, J. Kelly, D. Bell, W. Liu, “Learning Bayesian networks from data: an information-theory based approach”, Artificial Intelligence, Vol. 137, pp. 43–90, 2002.
D.S. Touretzky, M.C. Mozer, M.E. Hasselmo, Advances in Neural Information Processing Systems 8, Cambridge, MA, USA, MIT Press, 1996.
J. Cheng, D. Bell, W. Liu, “Learning Bayesian networks from data: an efficient approach based on information theory”, Artificial Intelligence, Vol. 137, pp. 43–90, 2002.
X. Ding, M. Patel, C.C. Chan, “Molecular pathology of age related macular degeneration”, Progress in Retinal and Eye Research, Vol. 28, pp. 1–18, 2009.
J.H. Lin, P.J. Haug, “Exploiting missing clinical data in Bayesian network modeling for predicting medical problems”, Journal of Biomedical Informatics, Vol. 41, pp. 1–14, 2008.
S. Chakraborty, R.A. Guo, “Bayesian hybrid huberized support vector machine and its applications in highdimensional medical data”, Computational Statistics & Data Analysis, Vol. 55, pp. 1342–1356, 2011.
I. Stajduhar, B. Dalbelo-Basic, N. Bogunovic, “Impact of censoring on learning Bayesian networks in survival modelling”, Artificial Intelligence in Medicine, Vol. 47, pp. 199–217, 2009.
G. Lindgaard, C. Pyper, M. Frize, R. Walker, “Does Bayes have it? Decision support systems in diagnostic medicine”, International Journal of Industrial Ergonomics, Vol, 39, pp. 524–532, 2009.
Y. Ji, K. Tsui, K. Kim, “A two-stage empirical Bayes method for identifying differentially expressed genes”, Computational Statistics & Data Analysis, Vol. 50, pp. 3592–3604, 2006.
D.J. Nott, Z. Yu, E. Chan, C. Cotsapas, M.J. Cowley, J. Pulvers, R. Williams, P. Little, “Hierarchical Bayes variable selection and microarray experiments”, Journal of Multivariate Analysis, Vol. 98, pp. 852–872, 2007.
Y. Zhang, T. Niu, J.S. Liu, “A coalescence-guided hierarchical Bayesian method for haplotype inference”, American Journal of Human Genetics, Vol. 79, pp. 313–322, 2006.
A. Orun, H. Seker, “Development of a computer-based framework for cognitive behaviour identification by using Bayesian inference methods”, Computers in Human Behavior, Vol. 28, pp. 1332–1341, 2012.
F. Bernardi, G. Marchetti, “Modulation of thrombophilia genes by environmental factors”, Pathophysiology of Haemostasis and Thrombosis, Vol. 32, pp. 335–337, 2002.
D.A. Lane, P.J. Grant, “Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease”, Blood, Vol. 95, pp. 1517–1530, 2000.
S. Ye, F.R. Green, P.Y. Scarabin, V. Nicaud, L. Bara, S.J. Dawson, S.E. Humphries, A. Evans, G. Luc, J.P. Cambou, “The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study”, Thrombosis and Haemostasis, Vol. 74, pp. 837–841, 1995.
V. Salomaa, V. Stinson, J.D. Kark, A.R. Folsom, C.E. Davis, K.K. Wu, “Association of fibrinolytic parameters with early atherosclerosis. The ARIC study. Atherosclerosis Risk in Communities Study”, Circulation, Vol. 91, pp. 284–290, 1995.
J.P. Collet, G. Montalescot, E. Vicaut, A. Ankri, F. Walylo, C. Lesty, R. Choussat, F. Beygui, M. Borentain, N. Vignolles, D. Thomas, “Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality”, Circulation, Vol. 108, pp. 391–394, 2003.
X. Busquets, N.G. MacFarlane, D. Heine-Suner, M. Morla, L. Torres-Juan, A. Iglesias, J. Llado, J. Sauleda, A.G. Agusti, “Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease”, International Journal of Chronic Obstructive Pulmonary Disease, Vol. 2, pp. 329–334, 2007.
J. Wagner, A.H. Jan Danser, F.H. Derkx, T.V. de Jong, M. Paul, J.J. Mullins, M.A. Schalekamp, D. Ganten, “Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system” British Journal of Ophthalmology, Vol. 80, pp. 159–163, 1996.
K. Lindpainther, M.A. Pfeffer, R. Kreutz, “A prospective evaluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease”, The New England Journal of Medicine, Vol. 332, pp. 706– 711, 1995.
B. Rigat, C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, F. Soubrier, “An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels”, Journal of Clinical Investigation, Vol. 86, pp. 1343–1346, 1990.
C. R¨ ocken, U. Lendeckel, J. Dierkes, S. Westphal, S. Carl-McGrath, B. Peters, S. Kr¨ uger, P. Malfertheiner, A. Roessner, M.P. Ebert, “The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism”, Clinical Cancer Research, Vol. 11, pp. 2526–2530, 200
H.K. Hamdi, J. Reznik, R. Castellon, S.R. Atilano, J.M. Ong, N. Udar, J.H. Tavis, A.M. Aoki, A.B. Nesburn, D.S. Boyer, K.W. Small, D.J. Brown, M.C. Kenney, “Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration”, Biochemical and Biophysical Research Communications, Vol. 295, pp. 668–672, 2002.
H.K. Hamdi, R. Castellon, “ACE inhibition actively promotes cell survival by altering gene expression”, Biochemical and Biophysical Research Communications, Vol. 310, pp. 1227–1235, 2003.
H.J. Kostamaa, Z. Baharoglu, J.H. Tavis, S.E. Anorvel, A.S. Ratnayake, D.S.H. Kim, G. Resende, S. Blacka, D.S. Boyer, H.K. Hamdi, “The ACE Alu polymorphism contributes to neovascular AMD risk”, Investigative Ophthalmology & Visual Science, Vol. 45, e-abstract 2720, 2004.
F.M. van’t Hooft, S.J. von Bahr, A. Silveira, A. Iliadou, P. Eriksson, A. Hamsten, “Two common functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration”, Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 19, pp. 3063–3070, 1999.
E.T. Brown, G.M. Fuller, “Detection of a complex that associates with the B β fibrinogen G-455-A polymorphism”, Blood, Vol. 92, pp. 3286–3293, 1998.
W. Smith, P. Mitchell, S.R. Leeder, J.J. Wang, “Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study”, Archives of Ophthalmology, Vol. 116, pp. 583–587, 1998. P.L Lip, A.D. Blann, M. Hope-Ross, J.M. Gibson, G.Y. Lip, “Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction”, Ophthalmology, Vol. 108, pp. 705–710, 2001.
S. Shiose, Y. Hata, Y. Noda, Y. Sassa, A. Takeda, H. Yoshikawa, K. Fujisawa, T. Kubota, T. Ishibashi, “Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF”, Graefes Archive for Clinical and Experimental Ophthalmology, Vol. 242, pp. 777–783, 2004.
A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, J.S. Marks, “Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001”, Journal of the American Medical Association, Vol. 289, pp. 76–79, 2003.
C. Delcourt, F. Michel, A. Colvez, A. Lacroux, M. Delage, M.H. Vernet, POLA Study Group, “Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study”, Ophthalmic Epidemiology, Vol. 8, pp. 237–249, 2001.
B.E. Klein, R. Klein, K.E. Lee, S.C. Jensen, “Measures of obesity and age-related eye diseases”, Ophthalmic Epidemiology, Vol. 8, pp. 251–262, 2001.
Age-Related Eye Disease Study Research Group, “Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3”, Ophthalmology, Vol. 107, pp. 2224–2232, 2000.
A. Mavri, M.C. Alessi, D. Bastelica, O. Geel-Georgelin, F. Fina, J.T. Sentocnik, M. Stegnar, I. Juhan-Vague, “Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss”, Diabetologia, Vol. 44, pp. 2025–2031, 200
R.P. Czekay, K. Aertgeerts, S.A. Curriden, D.J. Loskutoff, “Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins”, Journal of Cell Biology, Vol. 160, pp. 781–791, 2003.
L. Devy, S. Blacher, C. Grignet-Debrus, K. Bajou, V. Masson, R.D. Gerard, A. Gils, G. Carmeliet, P. Carmeliet, P.J. Declerck, A. Noel, J.M. Foidart, “The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent”, Federation of American Societies for Experimental Biology Journal, Vol. 16, pp. 147–154, 2002.
V. Lambert, C. Munaut, P. Carmeliet, R.D. Gerard, P.J. Declerck, A. Gils, C. Claes, J.M. Foidart, A. Noel, J.M. Rakic, “Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials”, Investigative Ophthalmology & Visual Science, Vol. 44, pp. 2791–2797, 2003.
P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J. Boers, M. den Heijer, L.A. Kluijtmans, L.P. van den Heuvel, R. Rozen, “A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase”, Nature Genetics, Vol. 10, pp. 111–113, 1995.
K. Coral, R. Raman, S. Rathi, M. Rajesh, K.N. Sulochana, N. Angayarkanni, P.G. Paul, S. Ramakrishnan, “Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration agerelated macular degeneration”, Eye, Vol. 20, pp. 203–207, 2006.
G. Kamburoglu, K. Gumus, S. Kadayifcilar, B. Eldem, “Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration”, Graefes Archive for Clinical and Experimental Ophthalmology, Vol. 24, pp. 565–569, 2006.
I. Terruzzi, P. Senesi, I. Fermo, G. Lattuada, L. Luzi, “Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity?”, Journal of Endocrinological Investigation, Vol. 30, pp. 747–753, 2007.